Cargando…
Small interfering RNA-induced silencing lncRNA PVT1 inhibits atherosclerosis via inactivating the MAPK/NF-κB pathway
Atherosclerosis (AS) is a chronic disease of the arterial wall. The role of lncRNAs in AS has been acknowledged. This study investigated the role of lncRNA plasmacytoma variant translocation 1 (PVT1) in AS via the MAPK/NF-κB pathway. Serum samples were collected from AS and non-AS patients. Serum le...
Autores principales: | Du, Hong, Zhang, Hui, Yang, Rong, Qiao, Li, Shao, Huiyu, Zhang, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610127/ https://www.ncbi.nlm.nih.gov/pubmed/34775377 http://dx.doi.org/10.18632/aging.203696 |
Ejemplares similares
-
LncRNA VINAS regulates atherosclerosis by modulating NF-κB and MAPK signaling
por: Simion, Viorel, et al.
Publicado: (2020) -
Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1
por: Wu, Tingrui, et al.
Publicado: (2022) -
LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
por: Chen, Ying, et al.
Publicado: (2018) -
LncRNA PVT1 Suppresses the Progression of Renal Fibrosis via Inactivation of TGF-β Signaling Pathway
por: Cao, Lu, et al.
Publicado: (2020) -
LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2020)